| Literature DB >> 27417441 |
Krzysztof Szklanny1, Ryszard Gubrynowicz2, Katarzyna Iwanicka-Pronicka3, Anna Tylki-Szymańska4.
Abstract
BACKGROUND: Pompe disease is a progressive metabolic myopathy. Disease progression is characterized, among other features, by progressive dysfunction of the voice apparatus. The aim of this study was to employ electroglottographic, acoustic and nasalance measurement methods on patients with late-onset Pompe disease in order to provide detailed information on the effect of the disease on voice quality. Voice quality is the key factor for estimating the effectiveness of ERT in late-onset Pompe disease. The study compared clinical phoniatric examination with electroglottographic, acoustic and nasalance measurement methods. The consistency of the aforementioned analyses was assessed.Entities:
Keywords: Acoustic methods; Electroglottography; Genetic disorder; Metabolic disorders; Myopathy; Nasalance measurement; Pompe disease; Vocal folds; Voice disorders; Voice quality
Mesh:
Year: 2016 PMID: 27417441 PMCID: PMC4946183 DOI: 10.1186/s13023-016-0480-5
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.123
Patient demographics
| ID | Gender | Current age years | Age of first symptoms years | Age of diagnosis years | Years on ERT | Mutation | Form |
|---|---|---|---|---|---|---|---|
| 1 | F | 11.8 | no symptoms, family screening | 2 | 7 | IVS1-13T>G/c.2662G>T | Juv |
| 2 | M | 15.5 | no symptoms, family screening | 6 | 7 | IVS1-13T>G/c.2662G>T | Juv |
| 3 | F | 17.9 | 2 | 2.5 | 7 | IVS1-13T>G/c.307T>G | Juv |
| 4 | M | 25.6 | 6 | 15 | 7 | IVS1-13T>G/c.2662G>T | Juv |
| 5 | F | 8.3 | 0.5 | 2 | 6 | L291F, 871C>T/R600C, 1798C>T | Juv |
| 6 | F | 7.5 | 1 | 1.5 | 6.5 | 2495delCA (ex18)/2495delCA (ex18) | Juv |
| 7 | M | 8.5 | no symptoms, family screening | 0.6 | 6 | G377S c.2495_2496 delCA | Juv |
| 8 | F | 14.8 | 3 | 4 | 8 | C1129G>A/c.2495_2496 delCA | Juv |
| 9 | M | 17.8 | 3.5 | 4 | 7 | IVS1-13T>G/c.925G>A | Juv |
| 10 | F | 40 | 6 | 31 | 7 | c.364A>G/c.1796C>T | Adult |
| 11 | F | 31 | 7 | 25 | 7 | IVS1-13T>/C103G | Adult |
| 12 | M | 37.5 | 27 | 29 | 7 | c.364A>G/c.1796C>T | Adult |
| 13 | F | 39 | 25 | 34 | 3 | IVS1-13T>G/C103G, 307T>G | Adult |
| 14 | M | 46.5 | 35 | 40 | 7 | IVS1-13T>G/c.307T>G | Adult |
| 15 | F | 53.8 | 30 | 46 | 5.5 | IVS1-13T>G/525delT | Adult |
| 16 | M | 34.8 | 15 | 25 | 7 | IVS1-13T>G/c.307T>G | Adult |
| 17 | M | 53.8 | 33 | 48 | 8 | IVS1-13T>G/C103G, 307T>G | Adult |
| 18 | M | 37.8 | 28 | 32 | 5 | IVS1-13T>G/c.307T>G | Adult |
| 19 | F | 33.8 | 26 | 30 | 5 | IVS1-13T>G/c.307T>G | Adult |
Table 1. Juv - juvenile
Laryngological examination results in patients with late-onset Pompe disease
| ID | Czermak score | Oral cavity | Nose | Ears |
|---|---|---|---|---|
| 1 | ND | N | DSN | N |
| 2 | ND | N | N | N |
| 3 | 2 | SP atonic, LMPh | N | N |
| 4 | ND | SP atonic, LMPh | N | N |
| 5 | 2 | Tonsillar hypertrophy, Short SP, Short SP | OMS bil | |
| 6 | 2 | SP atonic, short LMPh | N | N |
| 7 | 2 | Short atonic SP LMPh, atonic tongue | Conchal O | N |
| 8 | 2 | Short atonic SP, LMPh, atonic tongue | DSN | N |
| 9 | 0 | N | DSN | Epitympanal retr. |
| 10 | 1 | Short atonic SP, LMPh Lack of pharyngeal reflexes, Geographic tongue, Malocclusion (open bite) | N | N |
| 11 | 0 | N - Normal palate | N | N |
| 12 | 0 | SP LMPh | N | N |
| 13 | ND | ND | ND | ND |
| 14 | 0 | Long slender, movable, SP | DSN | N |
| 15 | 1 | N - Normal palate | N | Min. retractions of the drums |
| 16 | 0 | N - Normal palate | N | N |
| 17 | 0 | N - Normal palate Hypertrofia Tonsillae, | N | Osteoma in the right external auditory meatus |
| 18 | 1 | Short SP, PPHI, LMPh | DSN | N |
| 19 | 1 | Short SP, PPHI | Conchal O | Epitympanal retr. |
Table 2. SP – soft palate; LMPh – limited mobility during phonation; DSN – deviation of nasal septum; OMS – otitis media secretoria; PPHI – palatopharyngeal insufficiency; retr – retractions; ND – not done
Video-laryngoscopic examination results in patients with late-onset Pompe disease
| ID | Larynx diagnosis | Age of dysphonia/duration | GRBAS | MPT | Vestibulum of larynx | Vocal folds | Arytenoid area |
|---|---|---|---|---|---|---|---|
| 1 | N | No | 00000 | 6 s. | N | GI pp, VF thickened, thick mucus | Min. C |
| 2 | N | No | 00000 | 8 s. | N | Min. VF thickened | N |
| 3 | GI Laryngeal tremor | No data | 00100 | 10 s. | N | GI mp, VF tremor thick mucus on VF | C, O |
| 4 | N | No data | 10100 | 4 s. | N | VFC, mucus on VF | N |
| 5 | Hyperfunctional dysphonia | No data | 00001 | 10 s. | Phonation of VsP | N | C |
| 6 | No data | No data | No data | No data | No data | No data | No data |
| 7 | GI | 4 H, silent soundless matte V | 00220 | 12 s. | N | GI mp | Min. C, O |
| 8 | GI | 13/0.1, silent soundless matte V | 10110 | 12 s. | N | GI mp | C, O, mucus retention |
| 9 | N | No | 00000 | 20 s. | N | N | N |
| 10 | GI Laryngitis posterior | 25/10 H | 10000 | 15 s. | N | GI | C, O Laryngitis posterior |
| 11 | N | No | 00000 | 15 s | N | N | N |
| 12 | GI | 30/8 morning H cough | 00000 | 18 s. | N | GI mp | Min. C |
| 13 | No data | No data | No data | No data | No data | No data | No data |
| 14 | GI | 37/10 | 00110 | 8 s. | Enlarged rVsF covers rVF | GI Oblique orientation of glottis. | N |
| 15 | GI | No V fatigue | 00110 | 11 s. | N | GI mp. VF C | C, O |
| 16 | N | No | 00100 | 5 s. | N | VF thickened, tremor | Min. C, O |
| 17 | GI | 38/4 | 00100 | 22 s. | N | GI mp | C, O |
| 18 | GI | No V fatigue | 10000 | 5 s. | N | GI mp | Min. C. As. r aryt. Moved forward |
| 19 | GI | No data | 00100 | 4 s. | N | GI mp | N |
Table 3. GI - Glottal insufficiency; VF – vocal folds; VsF – vestibular folds; C – congestion; O - oedema; mp - middle part of the glottis; Min. – minimal; H – hoarseness; V – voice; r – right; N – normal, MPT –maximum phonation time
Coefficients for PS, NAQ, HRF, CPPv, CQ H and SQ values were obtained during prolonged phonation of /a/. In addition, the CQ H coefficient was calculated for its fragments
| ID | PS | NAQ | HRF | CPPv | CQ H | CQ H 2 sec. | CQ H 1sec. | SQ |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.21 | 0.11 | 14.72 | 11.90 | 0.45 | 0.38 | 0.36 | 0.28 |
| 2 | -0.40 | 0.10 | 34.20 | 11.36 | 0.31 | 0.27 | 0.26 | 0.85 |
| 3 | -0.22 | 0.09 | 13.60 | 11.81 | 0.45 | 0.43 | 0.42 | 0.30 |
| 4 | -0.39 | 0.09 | 30.97 | 10.95 | 0.36 | 0.34 | 0.34 | 0.60 |
| 5 | -0.06 | 0.08 | 16.10 | 11.57 | 0.20 | 0.18 | 0.17 | 1.60 |
| 6 | -0.12 | 0.11 | 12.70 | 11.36 | 0.34 | 0.34 | 0.31 | 0.38 |
| 7 | -0.02 | 0.16 | 13.60 | 11.25 | 0.30 | 0.29 | 0.28 | 0.28 |
| 8 | -0.16 | 0.11 | 11.90 | 11.54 | 0.37 | 0.32 | 0.30 | 0.38 |
| 9 | -0.50 | 0.12 | 37.49 | 10.31 | 0.23 | 0.23 | 0.23 | 1.20 |
| 10 | -0.43 | 0.19 | 17.51 | 11.57 | 0.29 | 0.28 | 0.27 | 0.84 |
| 11 | -0.29 | 0.08 | 19.20 | 12.49 | 0.46 | 0.45 | 0.43 | 0.13 |
| 12 | -0.26 | 0.13 | 17.11 | 11.46 | 0.44 | 0.40 | 0.37 | 0.29 |
| 13 | -0.33 | 0.14 | 17 | 12 | 0.43 | 0.39 | 0.38 | 0.43 |
| 14 | -0.48 | 0.15 | 21.85 | 11.93 | 0.37 | 0.34 | 0.33 | 0.45 |
| 15 | -0.10 | 0.12 | 12.70 | 11.40 | 0.39 | 0.36 | 0.35 | - |
| 16 | -0.43 | 0.11 | 29.30 | 11.52 | 0.24 | 0.22 | 0.21 | - |
| 17 | -0.44 | 0.18 | 26.67 | 11.76 | 0.32 | 0.30 | 0.28 | 1.08 |
| 18 | -0.34 | 0.10 | 30.64 | 11.24 | 0.30 | 0.28 | 0.27 | - |
| 19 | -0.09 | 0.09 | 13 | 11.51 | 0.35 | 0.34 | 0.33 | - |
Fig. 1Nasalization analysis of two sustained vowel sounds /i/ articulated by patients with late-onset Pompe disease (group 1). Two time signals (top), measurement of the nasalization coefficient (central) and time level variations in dB (bottom) of nose (continuous line) and mouth (broken line) signals. In healthy children’s voices, this coefficient does not exceed 20 %. This is typical for hypernasal speech